Search clinical trials for: OBI-999

Total 3136 results

BTL Industries Ltd.

Completed

rPMS and Radiofrequency for Abdominal Toning and Reduction of Subcutaneous Fat

Fat Burn

United States
BTL Industries Ltd.

Completed

Non-invasive Lipolysis on Human Thighs and Saddlebags

Adipose Tissue Reduction

Bulgaria
T3D Therapeutics, Inc.

Completed

Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
D-Pharm Ltd.

Completed

Effects Of DP-b99 On Neurological Function In Subjects With Acute Ischemic Hemispheric Stroke

Stroke | Cerebrovascular Disorders | Brain Ischemia

Israel, Germany
Memorial Health University Medical Center

Unknown

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

Breast Cancer | Sentinel Lymph Node Biopsy

United States
AbbVie

Active, not recruiting

A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States, Australia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Taiwan
Washington University School of Medicine
Lloyd J. Old STAR Program

Terminated

Mapping Draining Lymph Nodes in CNS Malignancies

Central Nervous System Neoplasms | Central Nervous System Tumor

United States
Navidea Biopharmaceuticals

Completed

Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging

Rheumatoid Arthritis

United States
Flare Therapeutics Inc.

Recruiting

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Advanced Solid Tumors Cancer | Advanced Urothelial Carcinoma | Open Label | Oral Drug Administration

United States
Amgen

Terminated

Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers

MUC17-positive Solid Tumors

United States, Korea, Republic of, Taiwan, Spain, Austria, France, Japan, Germany, Netherlands
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms

Fat Disorder

United States
BTL Industries Ltd.

Completed

Fat Reduction and Muscle Toning of Thighs

Fat Burn

United States
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Inner Thighs

Fat Disorder

United States
Takeda

Completed

A Study of Different Forms of TAK-994 in Healthy Adults

Healthy Participants

United States
BTL Industries Ltd.

Completed

Clinical Evaluation of the BTL-899 Device for Non-invasive Lipolysis on Human Fat Tissue

Improvement of Abdomen Appearance

Bulgaria
Carmot Australia First Pty Ltd
Carmot Therapeutics, Inc.

Recruiting

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes | Overweight or Obesity

Australia
Recursion Pharmaceuticals Inc.

Active, not recruiting

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994 (SYCAMORE)

Cerebral Cavernous Malformation

United States
Takeda

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male Participants

Healthy Volunteers

United States
Central Hospital, Nancy, France

Completed

Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera (DSPECT)

Myocardial Infarction | Ischemia

France
Far Eastern Memorial Hospital

Not yet recruiting

A Multi-center Cardiac PYP Scan Registry in Taiwan.

Heart Failure | Cardiac Amyloidosis

Taiwan
Navidea Biopharmaceuticals

Completed

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Melanoma | Breast Cancer

United States, Israel
University of California, San Diego

Recruiting

Dosimetry of Tc-99m-Tilmanocept

Diabetic Kidney Disease

United States
Takeda

Terminated

A Study of TAK-994 in Adults With Narcolepsy

Narcolepsy Type 1 (NT 1)

United States, Italy, Finland, Canada, Hungary, Czechia, France, Japan, Korea, Republic of, Spain
Takeda

Completed

A Study of TAK-919 in Healthy Japanese Adults (COVID-19)

Coronavirus Disease (COVID-19)

Japan
BTL Industries Ltd.

Completed

HIFEM for Arms, Lower Limbs, and Oblique Muscles

Muscle Tone Increased

United States
BTL Industries Ltd.

Unknown

Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen When Compared to a Sham Treatment

Improvement of Abdomen Appearance

Bulgaria
Concert Pharmaceuticals

Completed

Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease

Stage 3 Chronic Kidney Disease

United States
Navidea Biopharmaceuticals

Recruiting

Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA

Rheumatoid Arthritis

United States, United Kingdom
AbbVie

Active, not recruiting

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States, Australia, Belgium, Bulgaria, Canada, China, Czechia, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland and more
Amgen

Completed

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

Advanced Solid Tumors

Belgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
Navidea Biopharmaceuticals

Completed

Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT

Kaposi's Sarcoma

United States
OBI Pharma, Inc

Terminated

This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.

Locally Advanced Solid Tumors | Metastatic Solid Tumors

United States, Taiwan
Boston Scientific Corporation

Completed

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Hepatocellular Carcinoma

United States
Shanghai General Hospital, Shanghai Jiao Tong University...
NanoMab Technology (UK) Limited

Completed

99mTc Labeled Anti-PD-L1 sdAb SPECT/CT in Assessment of PD-L1 Expression in NSCLC

Non-Small Cell Lung Cancer

China
Northwestern University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Awareness and Self-Compassion Enhancing Narcolepsy Treatment (ASCENT)

Narcolepsy | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy

United States
Veloce BioPharma LLC

Completed

ALC-919 For The Treatment Of Common Warts

Verruca Vulgaris

United States
BTL Industries Ltd.

Active, not recruiting

Combination Treatment With BTL-899 and HPM-6000UF Devices

Pelvic Floor Disorders

United States
vTv Therapeutics

Completed

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
Navidea Biopharmaceuticals

Completed

Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes

Melanoma | Breast Cancer

United States
AbbVie

Available

Expanded Access to Telisotuzumab Vedotin

Non-Small Cell Lung Cancer (NSCLC)

Australia, Hong Kong, Israel, United States, Germany
Johns Hopkins University
Cardinal Health

Terminated

Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection

Breast Cancer

United States
BTL Industries Ltd.

Completed

Combination Treatment With BTL-899 and HPM-6000UF Devices II

Muscle Weakness

United States
AbbVie

Active, not recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers

B-cell Lymphoma

Israel, Puerto Rico, Turkey
Aerovance, Inc.

Completed

A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema

Atopic Eczema

United Kingdom
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

Eyelid Sebaceous Gland Carcinoma

United States
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Ictal SPECT With Intra-arterial Injection

Epilepsy

Belgium
Global Alliance for TB Drug Development

Completed

Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects

Tuberculosis | Tuberculosis, Pulmonary

United States
OBI Pharma, Inc

Recruiting

To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer (EGFR)

Non-small Cell Lung Cancer

Taiwan
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Stage IIA Fallopian Tube Cancer | Stage IIA Ovarian Cancer | Stage IIB Fallopian Tube Cancer | Stage IIB Ovarian Cancer | Stage IIC Fallopian Tube Cancer | Stage IIC Ovarian Cancer | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian... and other conditions

United States
Endocyte

Completed

Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients

Ovarian Cancer | Healthy Volunteers

United States

Search clinical trials for: OBI-999

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations